Abstract
Quantitative structure-activity relationships (QSAR) analyses have been attempted on a new set of 4- oxothiazolidines and 5-arylidines derivatives using linear free energy related (LFER) model of Hansch to explain the structural requirements for lipoxygenase inhibition. The QSAR study showed that successful correlation can be achieved for inhibitory activity of 4-oxothiazolidines and 5-arylidines (R > 0.9, Q2 > 0.7). The result of the QSAR study suggests the bulky substituents in the thiazolidine nucleus will decrease the binding affinity of 4-oxothiazolidines derivatives towards lipoxygenase indicated by negative contribution of molar refractivity and connolly accessible area. The positive contribution of topological parameters (BI, MTI, CC and TVC) illustrates that increase in branching and presence of heteroatom are favorable for lipoxygenase inhibitory activity.
Keywords: Quantitative structure-activity relationship, QSAR, lipoxygenase inhibitors, anti-inflammatory, substituted 4-oxathiazolidines, 5-arylidines
Mini-Reviews in Medicinal Chemistry
Title: Quantitative Structure Activity Relationship (QSAR) Analysis of Substituted 4-Oxothiazolidines and 5-Arylidines as Lipoxygenase Inhibitors
Volume: 10 Issue: 8
Author(s): A.N. Choudhary, A. Kumar and V. Juyal
Affiliation:
Keywords: Quantitative structure-activity relationship, QSAR, lipoxygenase inhibitors, anti-inflammatory, substituted 4-oxathiazolidines, 5-arylidines
Abstract: Quantitative structure-activity relationships (QSAR) analyses have been attempted on a new set of 4- oxothiazolidines and 5-arylidines derivatives using linear free energy related (LFER) model of Hansch to explain the structural requirements for lipoxygenase inhibition. The QSAR study showed that successful correlation can be achieved for inhibitory activity of 4-oxothiazolidines and 5-arylidines (R > 0.9, Q2 > 0.7). The result of the QSAR study suggests the bulky substituents in the thiazolidine nucleus will decrease the binding affinity of 4-oxothiazolidines derivatives towards lipoxygenase indicated by negative contribution of molar refractivity and connolly accessible area. The positive contribution of topological parameters (BI, MTI, CC and TVC) illustrates that increase in branching and presence of heteroatom are favorable for lipoxygenase inhibitory activity.
Export Options
About this article
Cite this article as:
Choudhary A.N., Kumar A. and Juyal V., Quantitative Structure Activity Relationship (QSAR) Analysis of Substituted 4-Oxothiazolidines and 5-Arylidines as Lipoxygenase Inhibitors, Mini-Reviews in Medicinal Chemistry 2010; 10 (8) . https://dx.doi.org/10.2174/138955710791572505
DOI https://dx.doi.org/10.2174/138955710791572505 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeted Radiotherapy for Malignant Gliomas
Current Drug Discovery Technologies Nitrogen, Oxygen or Sulfur Containing Heterocyclic Compounds as Analgesic Drugs Used as Modulators of the Nitroxidative Stress
Mini-Reviews in Medicinal Chemistry Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery RAN GTPase as a Target for Cancer Therapy: Ran Binding Proteins
Current Molecular Medicine Circulating Tumor Stem Cells as Biomarkers for Cancer Progression
Recent Patents on Biomarkers Circulating Biomarkers for Tumor Angiogenesis: Where Are We?
Current Medicinal Chemistry New Analogues of Mycophenolic Acid
Mini-Reviews in Medicinal Chemistry Cytokine and Immune System Abnormalities in Fibromyalgia and Other Central Sensitivity Syndromes
Current Rheumatology Reviews Nanomedicine based on Nucleic Acids: Pharmacokinetic and Pharmacodynamic Perspectives
Current Pharmaceutical Biotechnology Editorial [Hot Topic: Ulcerative Colitis: A Cinderella Story (Guest Editor: Silvio Danese)]
Current Drug Targets Curcumin, an Active Constiuent of the Ancient Medicinal Herb Curcuma longa L.: Some Uses and the Establishment and Biological Basis of Medical Efficacy
CNS & Neurological Disorders - Drug Targets Antioxidant Potential of Solvent Partitioned Extraction from Aqueous Extract of Gracilaria Tenuistipitata
Current Organic Chemistry Statins and Protein Prenylation in Cancer Cell Biology and Therapy
Anti-Cancer Agents in Medicinal Chemistry Efficient Colonic Delivery of DsiRNA by Pectin-Coated Polyelectrolyte Complex Nanoparticles: Preparation, Characterization and Improved Gastric Survivability
Current Drug Delivery EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance
Current Molecular Pharmacology Signal Transduction Inhibitors as Radiosensitizers
Current Medicinal Chemistry - Anti-Cancer Agents Polymeric Nanomicelles of Soluplus® as a Strategy for Enhancing the Solubility, Bioavailability and Efficacy of Poorly Soluble Active Compounds
Current Nanomedicine Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) The Functional Role of Long Non-coding RNA UCA1 in Human Multiple Cancers: a Review Study
Current Molecular Medicine Patent Selections
Recent Patents on Anti-Cancer Drug Discovery